Search

Search Constraints

You searched for: Author/Creator Man, C.

Search Results

2. CHILDHOOD AND ADOLESCENT HODGKIN REED-STERNBERG CELLS DEMONSTRATE UNIQUE GENE EXPRESSION SIGNATURE CONSISTENT WITH ONCOGENIC-INDUCED SENESCENCE. (October 2022)

3. Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies. Issue 2 (February 2020)

6. Two-drug regimen of dolutegravir plus lamivudine (DTG+3TC) is noninferior to dolutegravir plus tenofovir/emtricitabine (DTG+TDF/FTC) at 48 weeks in antiretroviral treatment-naive adults with HIV-1 infection: subgroup analyses in the GEMINI studies. Issue 1 (January 2019)